| S7285 |
NMS-873
|
NMS-873 is an allosteric and specific p97 inhibitor with IC50 of 30 nM that demonstrates potent selectivity for VCP/p97 compared to a panel of other AAA ATPases, Hsp90, and 53 additional analyzed kinases (IC50s >10 μM).
|
-
Nat Commun, 2025, 16(1):3546
-
Cancers (Basel), 2025, 17(13)2109
-
Cell, 2024, 187(21):6055-6070.e22
|
|
| S7199 |
DBeQ
|
DBeQ (JRF 12) is a selective, potent, reversible, and ATP-competitive p97 inhibitor with IC50 of 1.5 μM.
|
-
Cell Mol Immunol, 2024, 10.1038/s41423-024-01222-1
-
Virol Sin, 2023, 38(4):497-507
-
Virol J, 2022, 19(1):90
|
|
| S4921 |
MNS (3,4-Methylenedioxy-β-nitrostyrene)
|
MNS (3,4-Methylenedioxy-β-nitrostyrene) is a tyrosine kinase inhibitor that inhibits Syk, Src, and p97 with IC50 values of 2.5 μM, 29.3 μM, and 1.7 μM, respectively.
|
-
Journal of Biomedical Engineering, 2021, 38(5):903-910
-
Phytomedicine, 2019, 61:152859
-
J Biomol Struct Dyn, 2019, 10.1080/07391102.2019.1640133
|
|
| S9865 |
CB-5339
|
CB-5339 is a potent p97/Valosin Containing Protein (VCP) inhibitor with an IC50 of 9 nM.
|
-
Cell Rep, 2023, 42(11):113318
|
|
| S4453 |
NPD8733
|
NPD8733 is an inhibitor of cancer cell-enhanced fibroblast migration that specifically binds to valosin-containing protein (VCP)/p97, a member of the ATPase-associated with diverse cellular activities (AAA+) protein family.
|
|
|
| S0220 |
ML240
|
ML240 is an ATP-competitive inhibitor of p97 ATPase with an IC50 of 0.11 μM and a Ki of 0.22 μM.
|
|
|
| S8101 |
CB-5083
|
CB-5083 is a potent, selective, and orally bioavailable p97 AAA ATPase inhibitor with IC50 of 11 nM. Phase 1.
|
-
Nat Commun, 2025, 16(1):3546
-
EMBO J, 2025, 10.1038/s44318-025-00517-x
-
Proc Natl Acad Sci U S A, 2025, 122(27):e2426218122
|
|